Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men?
Objective To clarify the probability of low serum testosterone level as a risk factor for metabolic syndrome (MS) in middle-aged men, we measured serum total testosterone (TT) and assessed several metabolic factors because the direct risk for MS has not been investigated fully in men. Methods This s...
Gespeichert in:
Veröffentlicht in: | Urology (Ridgewood, N.J.) N.J.), 2013-10, Vol.82 (4), p.814-819 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 819 |
---|---|
container_issue | 4 |
container_start_page | 814 |
container_title | Urology (Ridgewood, N.J.) |
container_volume | 82 |
creator | Tsujimura, Akira Miyagawa, Yasushi Takezawa, Kentaro Okuda, Hidenobu Fukuhara, Shinichiro Kiuchi, Hiroshi Takao, Tetsuya Yamamoto, Ryohei Nishida, Makoto Yamauchi-Takihara, Keiko Moriyama, Toshiki Nonomura, Norio |
description | Objective To clarify the probability of low serum testosterone level as a risk factor for metabolic syndrome (MS) in middle-aged men, we measured serum total testosterone (TT) and assessed several metabolic factors because the direct risk for MS has not been investigated fully in men. Methods This study comprised 1150 men aged ≥30 years. Physical and laboratory variables were assessed. Analyses were conducted to determine the association between serum TT level and incidence risk of MS and MS factors by a separate logistic regression model. Results Mean (± standard deviation [SD]) serum TT level was 5.4 ± 1.7 ng/mL in the 1150 men, and only 92 men (8.0%) were classified as having MS by the Japanese criteria. In age-adjusted analyses, higher levels of serum TT were independently associated with a lower risk of MS (odds ratio, per SD decrement of TT, 2.3; 95% confidence interval [CI], 1.7-2.9). MS risk increased by lower quintile of TT: ORs were 15.1 (95% CI, 4.6-50.0) for first quintile, 8.8 (95% CI, 2.6-29.9) for second quintile, 5.8 (95% CI, 1.7-20.5) for third quintile, and 5.0 (95% CI, 1.4-17.9) for fourth quintile compared with highest quintile of TT. Age-adjusted ORs for the incidence of dichotomous components of MS per SD decrement of TT were 1.8 (95% CI, 1.5-2.3) for waist circumference, 1.6 (95% CI, 1.1-2.2) for dyslipidemia, and 1.5 (95% CI, 1.2-1.8) for hypertension. Conclusion We found that higher probability of MS was associated with lower levels of serum TT level in relatively healthy middle-aged Japanese men. |
doi_str_mv | 10.1016/j.urology.2013.06.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1438572078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009042951300767X</els_id><sourcerecordid>1438572078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-b95fd1255d192bc1ff6b6b4e49dbb17b0825533dc1c2518a6e8796e6704c9d373</originalsourceid><addsrcrecordid>eNqFkkFvFCEUx4nR2G31I2i4mHiZEZgBhouN2VjbZBsTWxNvhIE3le0sVJjR7Lcvk1018eKBcOD3_u_xy0PoFSU1JVS829ZzimO829eM0KYmoiaseYJWlDNZKaX4U7QiRJGqZYqfoNOct4QQIYR8jk5YS2SrpFih_irjTfyFbyFPMU-QYgC8jsFCmJKZfAzY4C8-3-MLY6eY8FDONUymj6O3-GYfXIo7wD7gSzDj9H2Pr71zI1TmDlwhw_kL9GwwY4aXx_sMfb34eLu-rDafP12tP2wqy6mYql7xwVHGuaOK9ZYOg-hF30KrXN9T2ZOuvDWNs9QyTjsjoJNKgJCktco1sjlDbw-5Dyn-mMt_9M5nC-NoAsQ5a9o2HZeMyK6g_IDaFHNOMOiH5Hcm7TUletGrt_qoVy96NRG66C11r48t5n4H7k_Vb58FeHMETLZmHJIJ1ue_nJRdJ-QSdH7goAj56SHpbD0U684nsJN20f93lPf_JNjRB1-a3sMe8jbOKRTbmurMNNE3yy4sq0AbQqSQ35pH9s-wFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1438572078</pqid></control><display><type>article</type><title>Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men?</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Tsujimura, Akira ; Miyagawa, Yasushi ; Takezawa, Kentaro ; Okuda, Hidenobu ; Fukuhara, Shinichiro ; Kiuchi, Hiroshi ; Takao, Tetsuya ; Yamamoto, Ryohei ; Nishida, Makoto ; Yamauchi-Takihara, Keiko ; Moriyama, Toshiki ; Nonomura, Norio</creator><creatorcontrib>Tsujimura, Akira ; Miyagawa, Yasushi ; Takezawa, Kentaro ; Okuda, Hidenobu ; Fukuhara, Shinichiro ; Kiuchi, Hiroshi ; Takao, Tetsuya ; Yamamoto, Ryohei ; Nishida, Makoto ; Yamauchi-Takihara, Keiko ; Moriyama, Toshiki ; Nonomura, Norio</creatorcontrib><description>Objective To clarify the probability of low serum testosterone level as a risk factor for metabolic syndrome (MS) in middle-aged men, we measured serum total testosterone (TT) and assessed several metabolic factors because the direct risk for MS has not been investigated fully in men. Methods This study comprised 1150 men aged ≥30 years. Physical and laboratory variables were assessed. Analyses were conducted to determine the association between serum TT level and incidence risk of MS and MS factors by a separate logistic regression model. Results Mean (± standard deviation [SD]) serum TT level was 5.4 ± 1.7 ng/mL in the 1150 men, and only 92 men (8.0%) were classified as having MS by the Japanese criteria. In age-adjusted analyses, higher levels of serum TT were independently associated with a lower risk of MS (odds ratio, per SD decrement of TT, 2.3; 95% confidence interval [CI], 1.7-2.9). MS risk increased by lower quintile of TT: ORs were 15.1 (95% CI, 4.6-50.0) for first quintile, 8.8 (95% CI, 2.6-29.9) for second quintile, 5.8 (95% CI, 1.7-20.5) for third quintile, and 5.0 (95% CI, 1.4-17.9) for fourth quintile compared with highest quintile of TT. Age-adjusted ORs for the incidence of dichotomous components of MS per SD decrement of TT were 1.8 (95% CI, 1.5-2.3) for waist circumference, 1.6 (95% CI, 1.1-2.2) for dyslipidemia, and 1.5 (95% CI, 1.2-1.8) for hypertension. Conclusion We found that higher probability of MS was associated with lower levels of serum TT level in relatively healthy middle-aged Japanese men.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2013.06.023</identifier><identifier>PMID: 24074976</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Humans ; Incidence ; Male ; Medical sciences ; Metabolic Syndrome - blood ; Metabolic Syndrome - epidemiology ; Nephrology. Urinary tract diseases ; Risk Factors ; Testosterone - blood ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2013-10, Vol.82 (4), p.814-819</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c516t-b95fd1255d192bc1ff6b6b4e49dbb17b0825533dc1c2518a6e8796e6704c9d373</citedby><cites>FETCH-LOGICAL-c516t-b95fd1255d192bc1ff6b6b4e49dbb17b0825533dc1c2518a6e8796e6704c9d373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2013.06.023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27788673$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24074976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsujimura, Akira</creatorcontrib><creatorcontrib>Miyagawa, Yasushi</creatorcontrib><creatorcontrib>Takezawa, Kentaro</creatorcontrib><creatorcontrib>Okuda, Hidenobu</creatorcontrib><creatorcontrib>Fukuhara, Shinichiro</creatorcontrib><creatorcontrib>Kiuchi, Hiroshi</creatorcontrib><creatorcontrib>Takao, Tetsuya</creatorcontrib><creatorcontrib>Yamamoto, Ryohei</creatorcontrib><creatorcontrib>Nishida, Makoto</creatorcontrib><creatorcontrib>Yamauchi-Takihara, Keiko</creatorcontrib><creatorcontrib>Moriyama, Toshiki</creatorcontrib><creatorcontrib>Nonomura, Norio</creatorcontrib><title>Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men?</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objective To clarify the probability of low serum testosterone level as a risk factor for metabolic syndrome (MS) in middle-aged men, we measured serum total testosterone (TT) and assessed several metabolic factors because the direct risk for MS has not been investigated fully in men. Methods This study comprised 1150 men aged ≥30 years. Physical and laboratory variables were assessed. Analyses were conducted to determine the association between serum TT level and incidence risk of MS and MS factors by a separate logistic regression model. Results Mean (± standard deviation [SD]) serum TT level was 5.4 ± 1.7 ng/mL in the 1150 men, and only 92 men (8.0%) were classified as having MS by the Japanese criteria. In age-adjusted analyses, higher levels of serum TT were independently associated with a lower risk of MS (odds ratio, per SD decrement of TT, 2.3; 95% confidence interval [CI], 1.7-2.9). MS risk increased by lower quintile of TT: ORs were 15.1 (95% CI, 4.6-50.0) for first quintile, 8.8 (95% CI, 2.6-29.9) for second quintile, 5.8 (95% CI, 1.7-20.5) for third quintile, and 5.0 (95% CI, 1.4-17.9) for fourth quintile compared with highest quintile of TT. Age-adjusted ORs for the incidence of dichotomous components of MS per SD decrement of TT were 1.8 (95% CI, 1.5-2.3) for waist circumference, 1.6 (95% CI, 1.1-2.2) for dyslipidemia, and 1.5 (95% CI, 1.2-1.8) for hypertension. Conclusion We found that higher probability of MS was associated with lower levels of serum TT level in relatively healthy middle-aged Japanese men.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Risk Factors</subject><subject>Testosterone - blood</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkFvFCEUx4nR2G31I2i4mHiZEZgBhouN2VjbZBsTWxNvhIE3le0sVJjR7Lcvk1018eKBcOD3_u_xy0PoFSU1JVS829ZzimO829eM0KYmoiaseYJWlDNZKaX4U7QiRJGqZYqfoNOct4QQIYR8jk5YS2SrpFih_irjTfyFbyFPMU-QYgC8jsFCmJKZfAzY4C8-3-MLY6eY8FDONUymj6O3-GYfXIo7wD7gSzDj9H2Pr71zI1TmDlwhw_kL9GwwY4aXx_sMfb34eLu-rDafP12tP2wqy6mYql7xwVHGuaOK9ZYOg-hF30KrXN9T2ZOuvDWNs9QyTjsjoJNKgJCktco1sjlDbw-5Dyn-mMt_9M5nC-NoAsQ5a9o2HZeMyK6g_IDaFHNOMOiH5Hcm7TUletGrt_qoVy96NRG66C11r48t5n4H7k_Vb58FeHMETLZmHJIJ1ue_nJRdJ-QSdH7goAj56SHpbD0U684nsJN20f93lPf_JNjRB1-a3sMe8jbOKRTbmurMNNE3yy4sq0AbQqSQ35pH9s-wFQ</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Tsujimura, Akira</creator><creator>Miyagawa, Yasushi</creator><creator>Takezawa, Kentaro</creator><creator>Okuda, Hidenobu</creator><creator>Fukuhara, Shinichiro</creator><creator>Kiuchi, Hiroshi</creator><creator>Takao, Tetsuya</creator><creator>Yamamoto, Ryohei</creator><creator>Nishida, Makoto</creator><creator>Yamauchi-Takihara, Keiko</creator><creator>Moriyama, Toshiki</creator><creator>Nonomura, Norio</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men?</title><author>Tsujimura, Akira ; Miyagawa, Yasushi ; Takezawa, Kentaro ; Okuda, Hidenobu ; Fukuhara, Shinichiro ; Kiuchi, Hiroshi ; Takao, Tetsuya ; Yamamoto, Ryohei ; Nishida, Makoto ; Yamauchi-Takihara, Keiko ; Moriyama, Toshiki ; Nonomura, Norio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-b95fd1255d192bc1ff6b6b4e49dbb17b0825533dc1c2518a6e8796e6704c9d373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Risk Factors</topic><topic>Testosterone - blood</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsujimura, Akira</creatorcontrib><creatorcontrib>Miyagawa, Yasushi</creatorcontrib><creatorcontrib>Takezawa, Kentaro</creatorcontrib><creatorcontrib>Okuda, Hidenobu</creatorcontrib><creatorcontrib>Fukuhara, Shinichiro</creatorcontrib><creatorcontrib>Kiuchi, Hiroshi</creatorcontrib><creatorcontrib>Takao, Tetsuya</creatorcontrib><creatorcontrib>Yamamoto, Ryohei</creatorcontrib><creatorcontrib>Nishida, Makoto</creatorcontrib><creatorcontrib>Yamauchi-Takihara, Keiko</creatorcontrib><creatorcontrib>Moriyama, Toshiki</creatorcontrib><creatorcontrib>Nonomura, Norio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsujimura, Akira</au><au>Miyagawa, Yasushi</au><au>Takezawa, Kentaro</au><au>Okuda, Hidenobu</au><au>Fukuhara, Shinichiro</au><au>Kiuchi, Hiroshi</au><au>Takao, Tetsuya</au><au>Yamamoto, Ryohei</au><au>Nishida, Makoto</au><au>Yamauchi-Takihara, Keiko</au><au>Moriyama, Toshiki</au><au>Nonomura, Norio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men?</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>82</volume><issue>4</issue><spage>814</spage><epage>819</epage><pages>814-819</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>Objective To clarify the probability of low serum testosterone level as a risk factor for metabolic syndrome (MS) in middle-aged men, we measured serum total testosterone (TT) and assessed several metabolic factors because the direct risk for MS has not been investigated fully in men. Methods This study comprised 1150 men aged ≥30 years. Physical and laboratory variables were assessed. Analyses were conducted to determine the association between serum TT level and incidence risk of MS and MS factors by a separate logistic regression model. Results Mean (± standard deviation [SD]) serum TT level was 5.4 ± 1.7 ng/mL in the 1150 men, and only 92 men (8.0%) were classified as having MS by the Japanese criteria. In age-adjusted analyses, higher levels of serum TT were independently associated with a lower risk of MS (odds ratio, per SD decrement of TT, 2.3; 95% confidence interval [CI], 1.7-2.9). MS risk increased by lower quintile of TT: ORs were 15.1 (95% CI, 4.6-50.0) for first quintile, 8.8 (95% CI, 2.6-29.9) for second quintile, 5.8 (95% CI, 1.7-20.5) for third quintile, and 5.0 (95% CI, 1.4-17.9) for fourth quintile compared with highest quintile of TT. Age-adjusted ORs for the incidence of dichotomous components of MS per SD decrement of TT were 1.8 (95% CI, 1.5-2.3) for waist circumference, 1.6 (95% CI, 1.1-2.2) for dyslipidemia, and 1.5 (95% CI, 1.2-1.8) for hypertension. Conclusion We found that higher probability of MS was associated with lower levels of serum TT level in relatively healthy middle-aged Japanese men.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24074976</pmid><doi>10.1016/j.urology.2013.06.023</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-4295 |
ispartof | Urology (Ridgewood, N.J.), 2013-10, Vol.82 (4), p.814-819 |
issn | 0090-4295 1527-9995 |
language | eng |
recordid | cdi_proquest_miscellaneous_1438572078 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Biological and medical sciences Humans Incidence Male Medical sciences Metabolic Syndrome - blood Metabolic Syndrome - epidemiology Nephrology. Urinary tract diseases Risk Factors Testosterone - blood Urology |
title | Is Low Testosterone Concentration a Risk Factor for Metabolic Syndrome in Healthy Middle-aged Men? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A52%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20Low%20Testosterone%20Concentration%20a%20Risk%20Factor%20for%20Metabolic%20Syndrome%20in%20Healthy%20Middle-aged%20Men?&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Tsujimura,%20Akira&rft.date=2013-10-01&rft.volume=82&rft.issue=4&rft.spage=814&rft.epage=819&rft.pages=814-819&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/j.urology.2013.06.023&rft_dat=%3Cproquest_cross%3E1438572078%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1438572078&rft_id=info:pmid/24074976&rft_els_id=S009042951300767X&rfr_iscdi=true |